Effect of photodynamic therapy combined with interstitial chemotherapy for gliomas

Abstract

Abstract: Objective To investigate the therapeutic effect of photodynamic therapy (PDT) combined with interstitial chemo-therapy on gliomas after microsurgery. Methods Twenty-eight patients with glioma received microsurgery for glioma resection as much as possible, during which PDT was carried out and an Ommaya bursa implanted into the cavity left by the resected tumor. PDT was performed again 24 h after the operation and carmustine injected into the Ommaya bursa for interstitial chemotherapy at the different time after the operation. The follow-up study lasted for 2 years. Results Two of the 28 patients had relapse of glioma within 1 year after the operation, with the 1-year survival rate of 89.3% (25/28) and 2-year survival rate of 65.7% (17/28). Conclusions PDT combined with interstitial chemotherapy following microsurgery provides a safe and effective treatment of glioma, which can inhibit glioma growth, decrease the recurrence rate, prolong the patients’ survival and improve their quality of live.

CLC Number:

R739.41

CHEN Li-feng, KE Yi-quan, YANG Zhi-lin, WANG Song-qing, XU Ru-xiang. Effect of photodynamic therapy combined with interstitial chemotherapy for gliomas[J]. Journal of Southern Medical University, 2005, 25(01): 116-118.

References

[1] 孙燕.内科肿瘤学[M].北京:人民卫生出版社,2001.497-501.
[2] Harbaugh KS, Black PM. Strategies in the surgical management of malignant gliomas[J]. Semin Surg Oncol, 1998, 14(1): 26-33.
[3] Gaspar LE, Zamorano LJ, Shamsa F, et al. Permanent 125iodine implants for recurrent malignant gliomas [J]. Radiat Oncol Biol Phys, 1999, 43(5): 977-82.
[4] Halligan JB, Stelzer KJ, Rostomily RC, et al. Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas[J]. Int J Radiat Oncol Biol Phys, 1996, 35(3): 541-7.
[5] Crossen JR, Garwood D, Glatstein E. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy[J]. Clin Oncol, 1994, 12: 627-42.
[6] Burton EC, Prados MD. Malignant gliomas[J]. Curr Treat Options Oncol, 2000, 1(5): 459-68.
[7] Nieder C, Grosu AL, Molls M, et al. A comparison of treatment results for recurrent malignant gliomas [J]. Cancer Treat Rev, 2000,26(6): 397-409.
[8] Eljamel MS. New light on the brain: The role ofphotosensitizing agents and laser light in the management of invasive intracranial tumors[J]. Technol Cancer Res Treat, 2003, 2(4): 303-9.
[9] Gupta S, Dwarakanath BS, Muralidhar K, et al. Role of apoptosis in photodynamic sensitivity of human tumour cell lines [J]. Exp Biol,2003, 41(1): 33-40.
[10] Popovic EA, Kaye AH, Hill JS. Photodynamic therapy of brain tumors[J]. Clin Laser Med Surg, 1996, 14(5): 251-61.
[11] Goetz C, Hasan A, Stummer W. Experimental research photodynamic effects in perifocal, oedematous brain tissue[J]. Acta Neurochir (Wien), 2002, 144(2): 173-9.
[12] Muller PJ, Wilson BC. Photodynamic therapy for recurrent supratentorial glinmas[J]. Semin Surg Oncol, 1995, 11(5): 346-54.
[13] Mason JO, Fischer DH. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma [J]. Ophthalmology, 2003,110(6): 1241-4.